Ocular features in Alport syndrome: Pathogenesis and clinical significance

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 4, 2015, Pages 703-709

  Savige, Judy ^a,b   Sheth, Shivanand ^c,d   Leys, Anita ^e   Nicholson, Anjali ^d   Mack, Heather G ^a   Colville, Deb ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d BYL NAIR CHARITABLE HOSPITAL   (India)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; TUMSTATIN; AUTOANTIGEN; COL4A4 PROTEIN, HUMAN; COL4A5 PROTEIN, HUMAN; TYPE IV COLLAGEN ALPHA3 CHAIN;

ALPORT SYNDROME; CATARACT; CENTRAL FLECK RETINOPATHY; CORNEA CLOUDING; CORNEA DISEASE; CORNEA DYSTROPHY; CORNEA OPACITY; CORNEA ULCER; DISEASE ASSOCIATION; EYE EXAMINATION; EYE PHOTOGRAPHY; FOVEOPATHY; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HEARING IMPAIRMENT; HUMAN; KIDNEY FAILURE; OPTICAL COHERENCE TOMOGRAPHY; PATHOGENESIS; RERIPHERAL COALESCING RETINOPATHY; RETINA MACULA HOLE; RETINA MACULOPATHY; RETINA THINNING; RETINOPATHY; REVIEW; VISUAL ACUITY; VISUAL IMPAIRMENT; X CHROMOSOME LINKED DISORDER; ANIMAL; COMPLICATION; EYE DISEASES; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MUTATION; NEPHRITIS, HEREDITARY; PHENOTYPE; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR; VISUAL SYSTEM EXAMINATION;

ANIMALS; AUTOANTIGENS; COLLAGEN TYPE IV; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; EYE DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; NEPHRITIS, HEREDITARY; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS;

EID: 84926666577     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10581014     Document Type: Review

References (62)

1. Colville DJ, Savige J: Alport syndrome. A review of the ocular manifestations. Ophthalmic Genet 18: 161-173, 1997
2. Savige J, Colville D: Opinion:Ocular features aid the diagnosis of Alport syndrome. Nat Rev Nephrol 5: 356-360, 2009
3. Rhys C, Snyers B, Pirson Y: Recurrent corneal erosion associated with Alport’s syndrome. Rapid communication. Kidney Int 52: 208-211, 1997
4. Usui T, Ichibe M, Hasegawa S, Miki A, Baba E, Tanimoto N, Abe H: Symmetrical reduced retinal thickness in a patient with Alport syndrome. Retina 24: 977-979, 2004
5. Bower KS, Edwards JD, Wagner ME, Ward TP, Hidayat A: Novel corneal phenotype in a patientwith Alport syndrome. Cornea 28: 599-606, 2009
6. Rahman W, Banerjee S: Giant macular hole in Alport syndrome. Can J Ophthalmol 42: 314-315, 2007
7. Fawzi AA, Lee NG, Eliott D, Song J, Stewart JM: Retinal findings in patients with Alport Syndrome: Expanding the clinical spectrum. Br J Ophthalmol 93: 1606-1611, 2009
8. Temme J, Kramer A, Jager KJ, Lange K, Peters F, Muller GA, Kramar R, Heaf JG, Finne P, Palsson R, Reisæter AV, Hoitsma AJ, Metcalfe W, Postorino M, Zurriaga O, Santos JP, Ravani P, Jarraya F, Verrina E, Dekker FW, Gross O: Outcomes of male patients with Alport syndrome undergoing renal replacement therapy. Clin J Am Soc Nephrol 7: 1969-1976, 2012
9. Gross O, Licht C, Anders HJ, Hoppe B, Beck B, Tönshoff B, Höcker B, Wygoda S, Ehrich JH, Pape L, Konrad M, Rascher W, Dötsch J, Müller-Wiefel DE, Hoyer P, Knebelmann B, Pirson Y, Grunfeld JP, Niaudet P, Cochat P, Heidet L, Lebbah S, Torra R, Friede T, Lange K, Müller GA, Weber M; Study Group Members of the Gesellschaft fur Padiatrische Nephrologie: Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int 81: 494-501, 2012
10. Feingold J, Bois E, Chompret A, Broyer M, Gubler MC, Grünfeld JP: Genetic heterogeneity of Alport syndrome. Kidney Int 27: 672-677, 1985
11. Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL, Tryggvason K: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248: 1224-1227, 1990
12. Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y, Verellen-Dumoulin C, Chan B, Schröder CH, Smeets HJ, Reeders ST: Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8: 77-81, 1994
13. Buzza M, Wang YY, Dagher H, Babon JJ, Cotton RG, Powell H, Dowling J, Savige J: COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome. Kidney Int 60: 480-483, 2001
14. Buzza M, Wilson D, Savige J: Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome. Kidney Int 59: 1670-1676, 2001
15. Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY: Thin basement membrane nephropathy. Kidney Int 64: 1169-1178, 2003
16. Parkin JD, San Antonio JD, Pedchenko V, Hudson B, Jensen ST, Savige J: Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes. Hum Mutat 32: 127-143, 2011
17. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG: Alport’s syndrome, Goodpasture’s syndrome, and type IV collagen. N Engl J Med 348: 2543-2556, 2003
18. Kabosova A, Azar DT, Bannikov GA, Campbell KP, Durbeej M, Ghohestani RF, Jones JC, Kenney MC, Koch M, Ninomiya Y, Patton BL, Paulsson M, Sado Y, Sage EH, Sasaki T, Sorokin LM, Steiner-Champliaud MF, Sun TT, Sundarraj N, Timpl R, Virtanen I, Ljubimov AV: Compositional differences between infant and adult human corneal basement membranes. Invest Ophthalmol Vis Sci 48: 4989-4999, 2007
19. Savige J, Liu J, DeBuc DC, Handa JT, Hageman GS, Wang YY, Parkin JD, Vote B, Fassett R, Sarks S, Colville D: Retinal basement membrane abnormalities and the retinopathy of Alport syndrome. Invest Ophthalmol Vis Sci 51: 1621-1627, 2010
20. Hertz JM, Thomassen M, Storey H, Flinter F: Clinical utility gene card for: Alport syndrome. Eur J Hum Genet 20: 20201
21. Bateman JF, Boot-Handford RP, Lamande´ SR: Genetic diseases of connective tissues: Cellular and extracellular effects of ECM mutations. Nat Rev Genet 10: 173-183, 2009
22. Zhou J, Reeders ST: The alpha chains of type IV collagen. Contrib Nephrol 117: 80-104, 1996
23. Gunwar S, Ballester F, Noelken ME, Sado Y, Ninomiya Y, Hudson BG: Glomerular basement membrane. Identification of a novel disulfide-cross-linked network of alpha3, alpha4, and alpha5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome. J Biol Chem 273: 8767-8775, 1998
24. Kalluri R, Shield CF, Todd P, Hudson BG, Neilson EG: Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest 99: 2470-2478, 1997
25. Abrahamson DR, Isom K, Roach E, Stroganova L, Zelenchuk A, Miner JH, St John PL: Laminin compensation in collagen alpha3 (IV) knockout (Alport) glomeruli contributes to permeability defects. J Am Soc Nephrol 18: 2465-2472, 2007
26. Zeisberg M, Khurana M, Rao VH, Cosgrove D, Rougier JP, Werner MC, Shield CF, Werb Z, Kalluri R: Stage-specific action of matrix metalloproteinases influences progressive hereditary kidney disease. PLoS Med 3: e100, 2006
27. Rao VH, Meehan DT, Delimont D, Nakajima M, Wada T, Gratton MA, Cosgrove D: Role for macrophage metalloelastase in glomerular basement membrane damage associated with Alport syndrome. Am J Pathol 169: 32-46, 2006
28. Meehan DT, Delimont D, Cheung L, Zallocchi M, Sansom SC, Holzclaw JD, Rao V, Cosgrove D: Biomechanical strain causes maladaptive gene regulation, contributing to Alport glomerular disease. Kidney Int 76: 968-976, 2009
29. Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Verellen C, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schröder C, Sanak M, Krejcova S, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC: X-linked Alport syndrome: Natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol 11: 649-657, 2000
30. Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M: Metaanalysis of genotype-phenotype correlation in X-linked Alport syndrome: Impact on clinical counselling. Nephrol Dial Transplant 17: 1218-1227, 2002
31. Tan R, Colville D, Wang YY, Rigby L, Savige J Alport retinopathy results from“severe” COL4A5 mutations and predicts early renal failure. Clin J Am Soc Nephrol 5: 34-38, 2010
32. Persikov AV, Pillitteri RJ, Amin P, Schwarze U, Byers PH, Brodsky B: Stability related bias in residues replacing glycines within the collagen triple helix (Gly-Xaa-Yaa) in inherited connective tissue disorders. Hum Mutat 24: 330-337, 2004
33. Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, Weber M, Gross O, Netzer KO, Flinter F, Pirson Y, Dahan K, Wieslander J, Persson U, Tryggvason K, Martin P, Hertz JM, Schröder C, Sanak M, Carvalho MF, Saus J, Antignac C, Smeets H, Gubler MC: X-linked Alport syndrome: Natural history and genotype-phenotype correlations in girls and women belonging to 195 families: A “European Community Alport Syndrome Concerted Action” study. J Am Soc Nephrol 14: 2603-2610, 2003
34. Storey H, Savige J, Sivakumar V, Abbs S, Flinter FA: COL4A3/ COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. J Am Soc Nephrol 24: 1945-1954, 2013
35. Burke JP, Clearkin LG, Talbot JF: Recurrent corneal epithelial erosions in Alport’s syndrome. Acta Ophthalmol (Copenh) 69: 555-557, 1991
36. Ramamurthi S, Rahman MQ, Dutton GN, Ramaesh K: Pathogenesis, clinical features and management of recurrent corneal erosions. Eye (Lond) 20: 635-644, 2006
37. Herwig MC, Eter N, Holz FG, Loeffler KU: Corneal clouding in Alport syndrome. Cornea 30: 367-370, 2011
38. Teekhasaenee C, Nimmanit S, Wutthiphan S, Vareesangthip K, Laohapand T, Malasitr P, Ritch R: Posterior polymorphous dystrophy and Alport syndrome. Ophthalmology 98: 1207-1215, 1991
39. Grupcheva CN, Chew GS, Edwards M, Craig JP, McGhee CN: Imaging posterior polymorphous corneal dystrophy by in vivo confocal microscopy. Clin Experiment Ophthalmol 29: 256-259, 2001
40. Sabates R, Krachmer JH, Weingeist TA: Ocular findings in Alport’s syndrome. Ophthalmologica 186: 204-210, 1983
41. Sekundo W, Lee WR, Kirkness CM, Aitken DA, Fleck B: An ultrastructural investigation of an early manifestation of the posterior polymorphous dystrophy of the cornea. Ophthalmology 101: 1422-1431, 1994
42. Laganowski HC, Sherrard ES, Muir MG: The posterior corneal surface in posterior polymorphous dystrophy: A specular microscopical study. Cornea 10: 224-232, 1991
43. Cheong HI, Kashtan CE, Kim Y, Kleppel MM, Michael AF: Immunohistologic studies of type IVcollagen in anterior lens capsules of patients with Alport syndrome. Lab Invest 70: 553-557, 1994
44. Streeten BW, Robinson MR, Wallace R, Jones DB: Lens capsule abnormalities in Alport’s syndrome. Arch Ophthalmol 105: 1693-1697, 1987
45. Ohkubo S, Takeda H, Higashide T, Ito M, Sakurai M, Shirao Y, Yanagida T, Oda Y, Sado Y: Immunohistochemical andmolecular genetic evidence for type IV collagen alpha5 chain abnormality in the anterior lenticonus associated with Alport syndrome. Arch Ophthalmol 121: 846-850, 2003
46. Sonarkhan S, Ramappa M, Chaurasia S, Mulay K: Bilateral anterior lenticonus in a case of Alport syndrome: A clinical and histopathological correlation after successful clear lens extraction [published online ahead of print June 26, 2014]. BMJ Case Rep 2014 doi: 10.1136/bcr-2013-202036
47. Choi J, Na K, Bae S, Roh G: Anterior lens capsule abnormalities in Alport syndrome. Korean J Ophthalmol 19: 84-89, 2005
48. Vedantham V, Rajagopal J, Ratnagiri PK: Bilateral simultaneous anterior and posterior lenticonus in Alport’s syndrome. Indian J Ophthalmol 53: 212-213, 2005
49. Liu YB, Tan SJ, Sun ZY, Li X, Huang BY, Hu QM: Clear lens phacoemulsification with continuous curvilinear capsulorhexis and foldable intraocular lens implantation for the treatment of a patientwith bilateral anterior lenticonus due to Alport syndrome. J IntMed Res 36: 1440-1444, 2008
50. Nielsen CE: Lenticonus anterior and Alport’s syndrome. Acta Ophthalmol (Copenh) 56: 518-530, 1978
51. Mete UO, Karaaslan C, Ozbilgin MK, Polat S, Tap O, Kaya M: Alport’s syndrome with bilateral macular hole. ActaOphthalmol Scand 74: 77-80, 1996
52. Wang Y, Sivakumar V, Mohammad M, Colville D, Storey H, Flinter F, Dagher H, Savige J: Clinical and genetic features in autosomal recessive and X-linked Alport syndrome. Pediatr Nephrol 29: 391-396, 2014
53. Shaw EA, Colville D, Wang YY, Zhang KW, Dagher H, Fassett R, Guymer R, Savige J: Characterization of the peripheral retinopathy in X-linked and autosomal recessive Alport syndrome. Nephrol Dial Transplant 22: 104-108, 2007
54. Govan JA: Ocular manifestations of Alport’s syndrome: A hereditary disorder of basement membranes? Br J Ophthalmol 67: 493-503, 1983
55. Ahmed F, Kamae KK, Jones DJ, Deangelis MM, Hageman GS, Gregory MC, Bernstein PS: Temporal macular thinning associated with X-linked Alport syndrome. JAMA Ophthalmol 131: 777-782, 2013
56. Colville D, Wang YY, Tan R, Savige J: The retinal “lozenge” or “dull macular reflex” in Alport syndrome may be associated with a severe retinopathy and early-onset renal failure. Br J Ophthalmol 93: 383-386, 2009
57. Cervantes-Coste G, Fuentes-Paez G, Yeshurun I, Jimenez-Sierra JM: Tapetal-like sheen associated with fleck retinopathy in Alport syndrome. Retina 23: 245-247, 2003
58. Setälä K, Ruusuvaara P: Alport syndrome with hereditary macular degeneration. Acta Ophthalmol (Copenh) 67: 409-414, 1989
59. Saika S, Hayashi Y, Miyamoto T, Yoshitomi T, Ohnishi Y: Multiple retinal holes in the macular region: A case report. Graefes Arch Clin Exp Ophthalmol 240: 578-579, 2002
60. Shaikh S, Garretson B, Williams GA: Vitreoretinal degeneration complicated by retinal detachment in alport syndrome. Retina 23: 119-120, 2003
61. Pelit A, Oto S, Yilmaz G, Akova YA: Spontaneous rupture of the anterior lens capsule combined with macular hole in a child with Alport’s syndrome. J Pediatr Ophthalmol Strabismus 41: 59-61, 2004
62. Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F: Expert guidelines for the management of Alport syndrome and thin basementmembrane nephropathy. JAmSoc Nephrol 24: 364-375, 2013